MyFinsight
Home
About
Contact
bsx: the income statement
Download
Download image
Non Us
$1,770M
(9.53%↑ Y/Y)
US
$3,294M
(27.03%↑ Y/Y)
Net sales
$5,065M
(20.34%↑ Y/Y)
Gross profit
$3,542M
(22.26%↑ Y/Y)
Cost of products sold
(excluding amortization...
$1,523M
(16.08%↑ Y/Y)
Operating income (loss)
$1,048M
(42.97%↑ Y/Y)
Operating expenses
$2,494M
(15.25%↑ Y/Y)
Restructuring net charges
(credits)
-$8M
(-200.00%↓ Y/Y)
Income (loss)before
income taxes
$939M
(40.36%↑ Y/Y)
Other, net
-$23M
(-264.29%↓ Y/Y)
Interest expense
$87M
(10.13%↑ Y/Y)
Contingent consideration
net expense...
$11M
(147.83%↑ Y/Y)
Amortization expense
$225M
(9.76%↑ Y/Y)
Royalty expense
$12M
(140.00%↑ Y/Y)
Research and development
expenses
$514M
(26.29%↑ Y/Y)
Selling, general and
administrative expenses
$1,741M
(11.46%↑ Y/Y)
Net income (loss)
$755M
(61.32%↑ Y/Y)
Income tax expense
(benefit)
$183M
(-8.50%↓ Y/Y)
Net income (loss)
attributable to boston...
$755M
(60.98%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
safari-pinned-tab-svg
BOSTON SCIENTIFIC CORP (BSX)
safari-pinned-tab-svg
BOSTON SCIENTIFIC CORP (BSX)